Jazz Pharmaceuticals, Inc. 401k Plan — Form 5500 plan (Jazz Pharmaceuticals, Inc.)

Plain-English plan summary

According to public Form 5500 filings published through the U.S. Department of Labor (DOL) Employee Benefits Security Administration (EBSA) via the EFAST2 system, Jazz Pharmaceuticals, Inc. 401k Plan is a benefit plan reported by Jazz Pharmaceuticals, Inc. under EIN 05-0563787 and plan number 001. The latest loaded filing year is 2023. The filing reports 1,716 participants and $296,711,349 in end-of-year plan assets, where available in the loaded dataset.

Key reported metrics

Plan sponsor
Jazz Pharmaceuticals, Inc.
EIN
05-0563787
Plan number
001
Plan type
2
Location
Palo Alto, CA
Latest filing year
2023
Participants
1,716
End-of-year plan assets
$296,711,349

Form 5500 filing history

Filings loaded for this plan
Filing yearParticipantsSchedulesFiling
20231,716H, C20240731124128NAL0012681315001

Reported financial statement (2023 · Schedule H)

Net assets

Total assets (EOY)
$296,711,349
Total liabilities (EOY)
$0
Net assets (EOY)
$296,711,349
Net assets (BOY)
$190,425,587

Income & contributions

Employer contributions
$13,778,845
Participant contributions
$27,218,961
Total contributions
$52,319,405
Total income / additions
$98,793,596

Expenses & distributions

Benefits paid
$22,670,706
Administrative expenses
$102,709
Total expenses
$22,798,455
Net increase / (decrease)
$75,995,141

Service provider compensation (Schedule C)

Reported service provider compensation
ProviderServiceDirect comp.Indirect comp.Year
Fidelity Investments InstitutionalRECORDKEEPER$102,709$02023

Related Form 5500 pages